Menu
Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 20,909 | Dovepress* | 14,286+ | 1,938 | 16,224 | |
| PubMed Central* | 6,623 | 991 | 7,614 | ||
| Totals | 20,909 | 2,929 | 23,838 | ||
| *Since 23 January 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar